Company news

Resverlogix Corp. news in 2026

Resverlogix Corp.'s news releases, calls and decks from 2026, newest first.

View company

Resverlogix Announces Publication of Scientific Journal Articles Relating to Apabetalone's Prevention of Heart Failure

September 10, 2026

Resverlogix Announces Voting Results from the 2026 Meeting of Shareholders

June 25, 2026

Resverlogix Closes US$2 Million Shares-for-Interest Private Placement

May 19, 2026

Financial Statement Q1 2026

May 15, 2026

MD&A Q1 2026

May 15, 2026

Resverlogix Announces One-Year Extension of Debenture

May 11, 2026

Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO

April 16, 2026

Financial Statement Q4 2025

April 10, 2026

Resverlogix Corp. Announces Issuance of MCTO by ASC

April 2, 2026

Resverlogix Corp. Provides Bi-Weekly MCTO Status Update

March 31, 2026

Resverlogix Announces Delay in Filing of Annual Financial Statements, AIF, and MD&A

March 17, 2026

Resverlogix Closes $2.8 Million Shares-for-Interest Private Placement

February 17, 2026

Decks in 2026